NIZATIDINE Side Effects

7018885-1 | Alopecia
on Sep 14, 2010 Female patient from UNITED KINGDOM , 77 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: alopecia. Nizatidine dosage: .

6939072-9 | Dysgeusia
Patient was taking Nizatidine (View Usage). Patient had the following side effects: dysgeusia on Apr 27, 2010 from UNITED STATES Additional patient health information: Female patient , 55 years of age, weighting 235.0 lb, was diagnosed with gastrooesophageal reflux disease, blood pressure increased and. Nizatidine dosage: . During the same period patient was treated with NEXIUM (View Nexium Review and Nexium Label ), TEKTURNA /01763602/ (View Tekturna /01763602/ Review and Tekturna /01763602/ Label ).

5764893-8 | Pyrexia, Rash Maculo-papular
Adverse event was reported on Jun 04, 2007 by a Female patient taking Nizatidine (View Usage) (Dosage: 300mg Per Day) was diagnosed with gastritis prophylaxis, palliative care (What is palliative care?) and. Location: UNITED STATES , 55 years of age, After Nizatidine was administered, patient had the following side effects: pyrexia, rash maculo-papular. During the same period patient was treated with PREDNISOLONE (30mg Per Day) (View Prednisolone Review and Prednisolone Label ), TICLOPIDINE HYDROCHLORIDE (200mg Per Day) (View Ticlopidine Hydrochloride Review and Ticlopidine Hydrochloride Label ), TEPRENONE (150mg Per Day) (View Teprenone Review and Teprenone Label ), NINJIN TO (View Ninjin-to Review and Ninjin-to Label ), AGARICUS (View Agaricus Review and Agaricus Label ), FUCOIDAN (View Fucoidan Review and Fucoidan Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

5729427-2 | Anaemia, Haematocrit Decreased, Multiple Myeloma
on Apr 24, 2008 Female patient from JAPAN , 92 years of age, was treated with Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia, haematocrit decreased, multiple myeloma (What is multiple myeloma?). Nizatidine dosage: . During the same period patient was treated with FLUITRAN (View Fluitran Review and Fluitran Label ), AMLODIN (View Amlodin Review and Amlodin Label ), PLAVIX (View Plavix Review and Plavix Label ).


5595518-2 | Pain, Pharmaceutical Product Counterfeit
on Jan 16, 2008 Female patient from UNITED STATES , 57 years of age, weighting 131.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Nizatidine (View Usage). Patient had the following side effects: pain (What is pain?), pharmaceutical product counterfeit. Nizatidine dosage: 150 Bid.

5242660-1 | No Therapeutic Response, Renal Impairment
Patient was taking Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: no therapeutic response, renal impairment on Feb 02, 2007 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with gastritis and. Nizatidine dosage: 150 Mg;bid;po. During the same period patient was treated with ETIZOLAM (View Etizolam Review and Etizolam Label ), BETAMETHASONE (View Betamethasone Review and Betamethasone Label ), ETODOLAC (View Etodolac Review and Etodolac Label ), MAGNESIUM OXIDE (View Magnesium Oxide Review and Magnesium Oxide Label ).

5127914-1 | Leukopenia, Neutrophil Percentage Decreased
Adverse event was reported on Sep 27, 2006 by a Female patient taking Nizatidine (View Usage) (Dosage: 150 Mg; Bid; Po) was diagnosed with gastritis and. Location: JAPAN , 63 years of age, Patient experienced the following unwanted or unexpected effects: leukopenia, neutrophil percentage decreased. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ).

5115431-4 | Pancytopenia
on Sep 08, 2006 Male patient from JAPAN , 72 years of age, was diagnosed with gastric ulcer and was treated with Nizatidine (View Usage). Patient had the following side effects: pancytopenia. Nizatidine dosage: 300 Mg; Qd; Po. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), CISPLATIN (View Cisplatin Review and Cisplatin Label ), IRINOTECAN HYDROCHLORIDE (View Irinotecan Hydrochloride Review and Irinotecan Hydrochloride Label ), GRANISETRON HYDROCHLORIDE (View Granisetron Hydrochloride Review and Granisetron Hydrochloride Label ), CARBAZOCHROME SODIUM SULFONATE (View Carbazochrome Sodium Sulfonate Review and Carbazochrome Sodium Sulfonate Label ), TRANEXAMIC ACID (View Tranexamic Acid Review and Tranexamic Acid Label ), AMBROXOL HYDROCHLORIDE (View Ambroxol Hydrochloride Review and Ambroxol Hydrochloride Label ). Patient was hospitalized.

5096456-4 | Dialysis, Nephritis Interstitial
on Aug 18, 2006 Female patient from JAPAN , 79 years of age, was treated with Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: dialysis (What is dialysis?), nephritis interstitial. Nizatidine dosage: 75 Mg; Bid; Po. During the same period patient was treated with MELOXICAM (View Meloxicam Review and Meloxicam Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), PYRIDOSTIGMINE BROMIDE (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ). Patient was hospitalized.

5071871-3 | Dialysis, Nephritis Interstitial
Patient was taking Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: dialysis (What is dialysis?), nephritis interstitial on Jul 20, 2006 from JAPAN Additional patient health information: Female patient , 79 years of age, . Nizatidine dosage: Po. During the same period patient was treated with MELOXICAM (View Meloxicam Review and Meloxicam Label ), ANASTROZOLE (View Anastrozole Review and Anastrozole Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), PYRIDOSTIGMINE BROMIDE (View Pyridostigmine Bromide Review and Pyridostigmine Bromide Label ). Patient was hospitalized.

5071870-1 | Leukopenia, Platelet Count Decreased, Red Blood Cell Count Decreased
Adverse event was reported on Jul 25, 2006 by a Female patient taking Nizatidine (View Usage) (Dosage: 150 Mg; Bid; Po) was diagnosed with gastritis and. Location: JAPAN , 63 years of age, Patient had the following side effects: leukopenia, platelet count decreased, red blood cell count decreased. During the same period patient was treated with VALSARTAN (View Valsartan Review and Valsartan Label ).

5066852-X | Pyrexia, White Blood Cell Count Decreased
on Jul 13, 2006 Male patient from JAPAN , 62 years of age, was diagnosed with gastric ulcer and was treated with Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: pyrexia, white blood cell count decreased. Nizatidine dosage: See Image. During the same period patient was treated with ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), ASPIRIN SOLUTION (View Aspirin Solution Review and Aspirin Solution Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), SEVELAMER HYDROCHLORIDE (View Sevelamer Hydrochloride Review and Sevelamer Hydrochloride Label ), METHYLDOPA (View Methyldopa Review and Methyldopa Label ). Patient was hospitalized.

5037336-X | Gynaecomastia
on Sep 30, 2005 Male patient from UNITED STATES , 38 years of age, weighting 139.0 lb, was diagnosed with dyspepsia and was treated with Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: gynaecomastia. Nizatidine dosage: 1 Dg;hs;po. During the same period patient was treated with LOPERAMIDE (View Loperamide Review and Loperamide Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), LANTUS (View Lantus Review and Lantus Label ), HUMALOG PEN (View Humalog Pen Review and Humalog Pen Label ).

5037335-8 | Idiopathic Thrombocytopenic Purpura
Patient was taking Nizatidine (View Usage). Patient had the following side effects: idiopathic thrombocytopenic purpura on Mar 09, 2005 from UNITED STATES Additional patient health information: Male patient , 76 years of age, was diagnosed with reflux oesophagitis and. Nizatidine dosage: 300 Mg;qd;po. During the same period patient was treated with ADENOSINE TRIPHOSPHATE, DISODIUM SALT (View Adenosine Triphosphate, Disodium Salt Review and Adenosine Triphosphate, Disodium Salt Label ), PANCREATIC ENZYMES (View Pancreatic Enzymes Review and Pancreatic Enzymes Label ), LACTOBACILLUS BIFIDUS, LYOPHILIZED (View Lactobacillus Bifidus, Lyophilized Review and Lactobacillus Bifidus, Lyophilized Label ), MECOBALAMIN (View Mecobalamin Review and Mecobalamin Label ), TAUROURSODESOXYCHOLIC ACID (View Tauroursodesoxycholic Acid Review and Tauroursodesoxycholic Acid Label ). Patient was hospitalized.

4977535-6 | Loss Of Consciousness, Malaise, Visual Brightness
Adverse event was reported on Apr 03, 2006 by a Female patient taking Nizatidine (View Usage) (Dosage: 150 Mg; Qd; Po) . Location: FRANCE , 59 years of age, After Nizatidine was administered, patient had the following side effects: loss of consciousness, malaise, visual brightness. During the same period patient was treated with ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ATARAX (View Atarax Review and Atarax Label ). Patient was hospitalized.

4971466-3 | Sepsis, Toxic Epidermal Necrolysis
on Mar 29, 2006 Female patient from JAPAN , 66 years of age, was treated with Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: sepsis (What is sepsis?), toxic epidermal necrolysis. Nizatidine dosage: Po.

4947509-X | Pancytopenia
on Mar 02, 2006 Male patient from JAPAN , 76 years of age, was diagnosed with gastric ulcer and was treated with Nizatidine (View Usage). Patient had the following side effects: pancytopenia. Nizatidine dosage: 300 Mg;qd;po. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ). Patient was hospitalized.

4865065-1 | Diarrhoea, Skin Ulcer
Patient was taking Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: diarrhoea, skin ulcer on Dec 20, 2005 from UNITED STATES Additional patient health information: Female patient , 44 years of age, weighting 130.0 lb, was diagnosed with gastritis, gastrooesophageal reflux disease and. Nizatidine dosage: 150 Mg Twice Daily Po.

4807990-3 | Gastric Polyps
Adverse event was reported on Oct 12, 2005 by a Male patient taking Nizatidine (View Usage) (Dosage: 300 Mg; Qd;) was diagnosed with abdominal discomfort, arthralgia and. Location: JAPAN , 74 years of age, Patient experienced the following unwanted or unexpected effects: gastric polyps. During the same period patient was treated with LORNOXICAM (LORNOXICAM) (12 Mg; Prn;) (View Lornoxicam (lornoxicam) Review and Lornoxicam (lornoxicam) Label ).

4750354-1 | Anaphylactoid Reaction, Arthralgia, Chills, Conjunctival Hyperaemia, Eye Pain, Headache, Hypersensitivity, Hyperthermia, Hyperventilation
on Aug 11, 2005 Female patient from JAPAN , 24 years of age, was diagnosed with gastritis and was treated with Nizatidine (View Usage). Patient had the following side effects: anaphylactoid reaction, arthralgia, chills, conjunctival hyperaemia, eye pain, headache (What is headache?), hypersensitivity, hyperthermia, hyperventilation. Nizatidine dosage: 75 Mg; Bid, Po. During the same period patient was treated with FERROUS SODIUM CITRATE (View Ferrous Sodium Citrate Review and Ferrous Sodium Citrate Label ). Patient was hospitalized.

4733564-9 | Conjunctival Disorder, Headache, Hyperthermia, Hyperventilation, Hypoaesthesia, Pharyngeal Oedema, Pyrexia
on Jul 21, 2005 Male patient from JAPAN , 24 years of age, was treated with Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: conjunctival disorder, headache (What is headache?), hyperthermia, hyperventilation, hypoaesthesia, pharyngeal oedema, pyrexia. Nizatidine dosage: Po. During the same period patient was treated with FERROUS SODIUM CITRATE (View Ferrous Sodium Citrate Review and Ferrous Sodium Citrate Label ). Patient was hospitalized.

4696878-7 | Anaemia Macrocytic, Bone Marrow Depression, Condition Aggravated, Pancytopenia
Patient was taking Nizatidine (View Usage). Patient experienced the following unwanted or unexpected effects: anaemia macrocytic, bone marrow depression, condition aggravated, pancytopenia on Jun 08, 2005 from Additional patient health information: Female patient , 40 years of age, was diagnosed with gastritis and. Nizatidine dosage: 300 Mg; Qd; Po. During the same period patient was treated with PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), LORMETAZEPAM (View Lormetazepam Review and Lormetazepam Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), ITOPRIDE HYDROCHLORIDE (View Itopride Hydrochloride Review and Itopride Hydrochloride Label ), BROTIZOLAM (View Brotizolam Review and Brotizolam Label ). Patient was hospitalized.

4654079-2 | Blood Iron Decreased, Bone Marrow Depression, Condition Aggravated, Pancytopenia, Platelet Count Increased
Adverse event was reported on Apr 20, 2005 by a Female patient taking Nizatidine (View Usage) (Dosage: 300 Mg; Qd; Po) was diagnosed with gastritis and. Location: , 40 years of age, Patient had the following side effects: blood iron decreased, bone marrow depression, condition aggravated, pancytopenia, platelet count increased. During the same period patient was treated with PAROXETINE HYDROCHLORIDE (View Paroxetine Hydrochloride Review and Paroxetine Hydrochloride Label ), ... (View ... Review and ... Label ), ETHYL LOFLAZEPATE (View Ethyl Loflazepate Review and Ethyl Loflazepate Label ), LORMETAZEPAM (View Lormetazepam Review and Lormetazepam Label ), TRIAZOLAM (View Triazolam Review and Triazolam Label ), FLUNITRAZEPAM (View Flunitrazepam Review and Flunitrazepam Label ), CLOXAZOLAM (View Cloxazolam Review and Cloxazolam Label ), ITOPRIDE HYDROCHLORIDE (View Itopride Hydrochloride Review and Itopride Hydrochloride Label ). Patient was hospitalized.

4617763-2 | Abdominal Tenderness, Aplastic Anaemia, Blood Disorder, Bone Marrow Depression, Crepitations, Diarrhoea, Embolism, Fungal Infection
on Mar 09, 2005 Female patient from , 55 years of age, was diagnosed with duodenal ulcer, basedow's disease and was treated with Nizatidine (View Usage). After Nizatidine was administered, patient had the following side effects: abdominal tenderness, aplastic anaemia, blood disorder, bone marrow depression, crepitations, diarrhoea, embolism, fungal infection (What is fungal infection?). Nizatidine dosage: 150 Mg; Qd. During the same period patient was treated with PROPYLTHIOURACIL (View Propylthiouracil Review and Propylthiouracil Label ), AMLODIPINE BESYLATE (View Amlodipine Besylate Review and Amlodipine Besylate Label ), VOGLIBOSE (VOGLIBOSE) (View Voglibose (voglibose) Review and Voglibose (voglibose) Label ), MECOBALAMIN (MECOBALAMIN) (View Mecobalamin (mecobalamin) Review and Mecobalamin (mecobalamin) Label ), ETIZOLAM (ETIZOLAM) (View Etizolam (etizolam) Review and Etizolam (etizolam) Label ), NEUTRAL INSULIN INJECTION (View Neutral Insulin Injection Review and Neutral Insulin Injection Label ). Patient was hospitalized.